Eurofins reinforces its footprint in the US environment testing market with the acquisition of Spectrum Analytical, Inc.
16 September 2015
Eurofins Scientific (EUFI.PA), the world leader in environment testing, announces the acquisition of certain assets of Spectrum Analytical, Inc. (“Spectrum”), a leading full-service environment testing provider with headquarters in Agawam, MA.
Founded in 1990, Spectrum employs 130 staff and offers a broad range of analytical services to support both commercial clients and government agencies to comply with major federal and state regulatory programs. Spectrum Analytical specializes in providing quality analytical data and exceptional customer service with a full range of test methods for sediments, soils, sludge, solid waste, hazardous waste, drinking water, groundwater, industrial wastewater, plant and animal tissue and air.
The company’s activities complement Eurofins’ competencies, and its markets augment the Group’s footprint in the Northeast US. Its addition into the Eurofins network demonstrates the Group’s commitment to expanding its presence and service offerings in the US market. In return, Spectrum Analytical gains access to Eurofins’ robust network capabilities and the latest technologies to further improve its service offering to its customers.
For more information about Eurofins Environment Testing US, please visit www.eurofinsus.com or contact:
Keith C. Wheatstone, PhD
Eurofins Environment Testing US
Phone: +1 973 454 1927
Notes for the editor:
About Eurofins Environment Testing US
The Eurofins U.S. environmental testing laboratories contribute to a clean and safe environment by providing market-leading laboratory testing, monitoring and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities. With a keen focus on client service, regulatory compliance and defensible data, the Eurofins environmental laboratories network in the US performs analysis of drinking water, groundwater, seawater, soil, air and tissue using state-of-the-art analytical methods to assess quality and impact on health and the environment.
Eurofins – a global leader in bio-analysis
Eurofins Scientific is the world leader in food, environment and pharmaceutical products testing. It is also one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.
With 19,000 staff in around 200 laboratories across 38 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.